Replies to post #35846 on Biotech Values

[DewDiligence]

LOL re QLTI:

“The decline in Visudyne sales has been more rapid than anticipated and, as a result, we are lowering our 2006 annual Visudyne sales range...” Bob Butchofsky, president and chief executive of QLT, said in a release accompanying the outlook.

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061019:MTFH60977_2...